Revised February 2018
Opioid-Related Overdose Deaths
In 2016, there were 1,762 opioid-related overdose deaths in Michigan—a rate of 18.5 deaths per 100,000 persons compared to the national rate of 13.3 deaths per 100,000. More than half of deaths, totaling 921 in 2016, were attributed to synthetic opioids and 727 were related to heroin (categories are not mutually exclusive).
Opioid Pain Reliever Prescriptions
In 2015, Michigan providers wrote 96.1 opioid prescriptions per 100 persons (9.5 million prescriptions). In the same year, the average U.S. rate was 70 opioid prescriptions per 100 persons (IMS Health, 2016).
Neonatal Abstinence Syndrome (NAS)
The incidence of NAS in Michigan has increased from 0.4 per 1,000 births in 2000 to 6.7 per 1,000 in 2013, a more than sixteenfold increase. The average across 28 states included in a 2013 analysis was 6.0 cases per 1,000 births (CDC, MMWR, 2014).
HIV Prevalence and HIV Diagnoses Attributed to Injection Drug Use (IDU)
- U.S. Incidence: In 2015, 9.1 percent (3,5941) of the 39,513 new diagnoses of HIV in the United States were attributed to IDU. Among new cases, 8.2 percent (2,6141) of cases among men and 13.2 percent (980) of cases among women were transmitted via IDU (CDC).
- U.S. Prevalence: In 2014, 955,081 Americans were living with a diagnosed HIV infection—a rate of 299.5 per 100,000 persons. Of these, 18.1 percent (131,0561) of males and 22.6 percent (52,013) of females were living with HIV attributed to IDU (CDC).
- State Incidence: Of the new HIV cases in 2015, 725 occurred in Michigan (a rate of nine infections per 100,000 people), with 5.1 percent1 of new cases in males and 11.0 percent of new cases in females attributed to IDU (AIDSVu).
- State Prevalence: In 2014, an estimated 14,944 persons were living with a diagnosed HIV infection in Michigan—a rate of 179 infections per 100,000 persons. Of these, 13.7 percent1 of males and 23.1 percent of females were living with HIV attributed to IDU (AIDSVu).
Hepatitis C (HCV) Prevalence and HCV Diagnoses Attributed to Injection Drug Use
- U.S. Incidence: In 2015, there were 181,871 reported cases of chronic HCV and 33,900 estimated cases of acute HCV2 (CDC). Where data were available, 64.2 percent of acute cases reported IDU (CDC).
- U.S. Prevalence: An estimated 3.5 million Americans are living with HCV, including approximately 2.7 million living with chronic infections (CDC).
- State Incidence: In 2015, Michigan reported 7,833 cases of chronic HCV and 84 cases of acute HCV at rates of 79.25 cases per 100,000 persons and 0.85 cases per 100,000 persons, respectively. Where data were available, more than 60 percent reported IDU. In a subgroup of IDU aged 18–29, 86.7 percent had HCV attributed to IDU (Michigan.gov).
- State Prevalence: As of 2015, an estimated 99,000 persons were living with HCV in Michigan (Michigan.gov).
- Michigan Department of Health and Human Services, Behavioral Health & Developmental Disability
- Centers for Disease Control and Prevention, Opioid Overdose
- Centers for Disease Control and Prevention, Annual Surveillance Report of Drug-Related Risks and Outcomes (2017)
- Substance Abuse and Mental Health Services Administration, Behavioral Health Barometer Michigan, Volume 4 (2017)
- Includes transmission to individuals with injection drug use as a risk factor.
- 2015 estimate after adjusting for under-ascertainment and under-reporting. Data for 2015 were unavailable for Alaska, Arizona, Connecticut, the District of Columbia, Hawaii, Iowa, Mississippi, New Hampshire, Rhode Island, and Wyoming.
Emerging Trends & Alerts
Get more information on Emerging Trends and Alerts, we will update this page with the latest research findings as they develop.
Get this Publication
NIH HEAL (Helping to End Addiction Long-term) Initiative
New Opioid Overdose Materials for Patients
Find information about addiction and mental health services in your area. You can search by state or zip code online or call the number. (SAMHSA)